Abstract
Hepatocellular carcinoma (HCC) is a major problem worldwide, with an estimated 1 million new cases diagnosed annually. Major risk factors are infections with hepatitis B virus (HBV) or hepatitis C virus (HCV). In Asia, the risk is as high as 30–65 per 100,000 persons per year, whereas in the United States, the incidence is 2 per 100,000 persons per year (1). Although cirrhosis is not present in all cases, it has been estimated to be present 70–90% of the time (2–5). The annual conversion rate of cirrhosis to HCC is 3–6% (6). Therefore, any surgical therapy must consider not only the cancer but also the underlying liver function and reserve. It is often the degree of liver dysfunction or reserve that will determine the optimal treatment. Only 10–15% of patients with HCC are eligible for hepatic resection (7–9). At present, surgical resection or liver transplantation offers the only chance for cure in the small subset of patients eligible. Contraindications to resection include extrahepatic involvement; multifocal, bilobar disease; inadequate hepatic reserve; or overall poor clinical condition of the patient.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;129:643–653.
Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 1988;15:1–31.
Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948–963.
Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors or hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47–53.
Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675–680.
Colombo M. Hepatocellular carcinoma: an overview. In: Viral Hepatitis and Liver Disease (Rizzeto M, Purcell RH, Gerin JL, Verme G, eds.), Springer-Verlag, New York, 1994, pp. 479–483.
McGahan JP, Dodd GD III. Radiofrequency ablation of liver: current status. Am J Roentgenol 2001;176:3–14.
Tsuzuki T, Sugioka A, Ueda M. Hepatic resection for hepatocellular carcinoma. Surgery 1990;107:511–520.
Choi TK, Lai ECS, Fan ST, et al. Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology 1990;37:172–175.
d’Arsonval MA. Action physiologique des courants alternatifs. CR Soc Biol 1891;43:283–286.
Siperstein AE, Gitomirski A. History and technological aspects of radiofrequency thermoablation. Cancer J 2000;6(suppl 4):s293–s303.
Beer E. Removal of neoplasms of the urinary bladder: a new method employing high frequency (oudin) currents through a cauterizing cystoscope. JAMA 1910;54:1768,1769.
Cushing H, Bovie WT. Electro-surgery as an aid to the removal of intracranial tumors. Surg Gynecol Obstet 1928;47:751–784.
Lounsberry W, Goldschmint V, Linke CA, et al. The early histologic changes following electrocoagulation. J Urol 1961;86:321–329.
McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990;25:267–270.
Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990;76:54–57.
Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Intervent Radiol 1993;8:97–103.
Rossi S, Di Stasi M, Buscarini L, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Scientific Am 1995;1:73–81.
McGahan JP, Brock JM, Tesluk H, et al. Hepatic ablation with use of radiofrequency electrocautery in the animal model. J Vasc Interv Radiol 1992;3:291–297.
Chamberlain RS, Fong Y. Radiofrequency thermal ablation of liver tumors. In: Surgery of the Liver and Biliary Tract, 3rd ed. (Blumgart LH, Fong Y, eds.), WB Saunders, Philadelphia, 2000, pp. 1589–1595.
Scudamore C. Volumetric radiofrequency ablation: technical considerations. Cancer J 2000;6(suppl 4):s316–s318.
Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995;2:399–404.
Haines DE. The biophysics of radiofrequency catheter ablation the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol 1993;16:586–591.
McGahan JP, Gu WZ, Brock JMP, et al. Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 1996;3:418–422.
Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996;3:636–644.
Lorentzen T, Christensen NE, Nolsle CP, Torp-Pedersen ST. Radiofrequency tissue ablation with cooled needle in vitro: ultrasonography, dose response, and lesion temperature. Acad Radiol 1997;4:292–297.
Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radio-frequency tissue ablation the treatment of liver metastases. Radiology 1997;202:205–210.
Goldstein RM, Orr DW, Meyer RL, Derrick GC, Westmoreland MV, Levy MF, et al. Treatment of hepatomas in cirrhotic patients with radiofrequency thermal ablation. Transplantation 2000;69(8 suppl):S137.
Pulvirenti A, Garbagnati F, Regalia E, et al. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. Trans Proc 2001;33:1516,1517.
Goldberg SN, Gazelle GS, Halpern EF, et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996;3:212–218.
Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determination of outcome. Ann Surg 1998;227:566–571.
Llovet JM, Milana R, Bru C, Bianchi L, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129.
Solbiati L, Goldberg SN, Ierance T, et al. Radiofrequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience. Radiology 1999;221:643–649.
Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996;167:759–768.
Solbiati L. New applications of ultrasonography: interventional ultrasound. Eur J Radiol 1998;27:S200–S206.
Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. Am J Roentgenol 2001;177:783–788.
Delva E, Camus Y, Nordlinger B, et al. Vascular occlusions for liver resection. Ann Surg 1989;209:297–304.
Curley SA, Davidson BS, Fleming RYD, et al. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surg Endoscopy 1997;11:729–733.
Dromain C, De Baere TJ, Elias D, Ducre M, Sabourin J, Vanel D. Follow-up imaging of liver tumors treated using percutaneous radio frequency therapy with helical CT and MRI imaging. Radiology 1999;219:382.
Choi H, Loyer EM, DuBrow RA, et al. Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 2001;21:S41–S54.
Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 2000;135:657–664.
Curley SA, Izzo F, Ellis LM, Vauthey JN, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381–391.
Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914–921.
Nicoli N, Casaril A, Marchiori L, Mangiante G, Hasheminia AR. Treatment of recurrent hepatocellular carcinoma by radiofrequency ablation. J Hepatobiliary Panc Surg 2001;8:417–421.
Bowles BJ, Machi J, Limm WML, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864–869.
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation. Cancer 2000;88:2452–2463.
Siperstein A, Garland A, Engle K, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106–113.
Chung MH, Wood TF, Tsioulias GJ, Rose DM, Bilchik AJ. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. Surg Endosc 2001;15:1020–1026.
Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600.
Elias D, Goharin A, Otmany E, et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 2000;26:763–769.
Goletti O, Lencioni R, Armillotta N, et al. Laparoscopic radiofrequency thermal ablation of hepatocarcinoma: preliminary experience. Surg Laparosc Endosc Percutan Tech 2000;10:284–290.
Cuschieri A, Bracken J, Boni L. Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumours. Endoscopy 1999;31:318–321.
Pearson AS, Izzo F, Fleming RYD, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592–599.
Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999;230:1–8.
Rossi S, Buscarini L, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998;170:1015–1022
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Goodman, M., Geller, D.A. (2005). Radiofrequency Ablation of Hepatocellular Carcinoma. In: Carr, B.I. (eds) Hepatocellular Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-844-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-59259-844-1_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-125-7
Online ISBN: 978-1-59259-844-1
eBook Packages: MedicineMedicine (R0)